相关实验视频

Updated: Jun 26, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

确定重大抑郁症潜在生物标志物:基于综合生物信息学和临床验证

Xiaogang Zhong^1,2,3, Yue Chen^2,3,4, Weiyi Chen^2,3,4

¹College of Basic Medicine, Chongqing Medical University, Chongqing, 400016, China.

Molecular neurobiology

|May 9, 2024

概括

研究人员确定了七个关键基因在主要抑郁症 (MDD) 患者中持续改变. 这种基因组显示出强大的诊断潜力,为MDD诊断和生物标志物发现提供了一个新的工具.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
生物标志物发现发现

背景情况:

大型抑郁症 (MDD) 缺乏客观的诊断生物标志物.
在MDD中观察到前额叶皮层 (PFC) 的转录变化.
识别具有诊断能力的特定,持续改变的基因至关重要.

研究的目的:

系统地识别MDD患者的PFC中强烈改变的基因.
在血液样本中验证这些基因作为潜在的生物标志物.
评估MDD基因组的诊断能力.

主要方法:

对MDD患者的基因表达综合 (GEO) PFC数据集进行系统搜索.
使用RRA和MetaDE方法进行差异基因表达 (DEG) 分析.
通过ELISA在临床血液队列和独立数据集中验证强大的DEG.
使用曲线下的面积 (AUC) 评估诊断功率.

主要成果:

在八个PFC数据集中确定了1468个独特的DEG (158名MDD患者,263名对照).
确定了290个强烈改变的DEG,其中七个枢纽基因 (SLC1A3,PON2,AQP1,EFEMP1,GJA1,CENPD,HSD11B1) 在血液中的蛋白质水平上显著下调.
七基因小组显示出高诊断效率 (AUC为0.85在公共数据集,0.92在临床队列).

结论:

一组由七个枢纽基因 (SLC1A3,PON2,AQP1,EFEMP1,GJA1,CENPD,HSD11B1) 组成的小组显示,MDD患者的下调显著.
这些基因与抑郁症严重程度相关,并具有强大的MDD诊断潜力.
这种基因面板代表了客观MDD诊断的有希望的工具.

关键词:

生物标志物生物标志物血液血液血液血液大型抑郁症主要是抑郁症.前额叶皮层前额叶皮层.

更多相关视频

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

相关概念视频

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...